Orrick represented SupplyPike on the deal. SPS Commerce acquired SupplyPike for approximately $119 million in cash, net of cash acquired and $87 million in SPS Commerce...
SPS Commerce’s Acquisition of SupplyPike
Serve Robotics’ $40 Million Common Stock Offering and Nasdaq Uplisting
Orrick Herrington & Sutcliffe represented Serve Robotics in the offering, and Sichenzia Ross Ference Carmel reprensted the sole book-running managers. Serve Robotics Inc. (the “Company” or “Serve”),...
Ichor Holdings’ $125 Million Shares Offering
Orrick represented TD Cowen and Stifel as joint book-running managers and representatives of several underwriters in the offering. Ichor Holdings, Ltd. executed a $125 million public offering....
Tidal Cyber’s $5 Million Seed Round
Orrick advised Squadra Ventures in the round. Tidal Cyber, the threat-informed defense company, announced that the company raised $5 million, led by Squadra Ventures with participation...
Kineta’s $3 Million Registered Direct Offering
Orrick Herrington & Sutcliffe LLP represented Kineta on the matter. Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology...
Fisker Inc.’s $150 Million Fundraise
Orrick Herrington & Sutcliffe LLP represented Fisker on the matter. Electric vehicle startup Fisker has announced plans to offer $170 million in unsecured convertible notes with...
Fisker’s $340 Million Notes Offering
Orrick represented Fisker on the deal. Fisker has closed on $340 million in unsecured convertible notes with an original issue discount of 12 percent, resulting in...
Catalyst Biosciences’ Reverse Merger with GNI Group
Orrick advised Catalyst Biosciences, Inc. on the deal. South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. announced its acquisition of the F351 program, a next-generation fibrosis drug,...
CIIG Capital Partners II’s Merger with Zapp
Orrick advised CIIG Capital Partners II on the deal, while Latham & Watkins represented Zapp in the transaction. CIIG Capital Partners II, a U.S. publicly listed...
Catalyst Biosciences’ $60 Million Sale of Complement Portfolio
Orrick advised Catalyst Biosciences, Inc. on the deal. South San Francisco-based biopharmaceutical company Catalyst Biosciences, Inc. (NASDAQ: CBIO) announced the sale of its complement asset portfolio for...
Fisker’s Launch of $350 Million At-the-Market Equity Program
Orrick advised Fisker on the deal. Fisker (NYSE: FSR) announced the establishment of its at-the-market equity program with J.P. Morgan Securities and Cowen and Company as...
COVA Acquisition’s $3.82 Billion De-Spac Merger with ECARX
UBS AG Hong Kong Branch(1) and Morgan Stanley Asia Limited acted as joint financial advisors to ECARX. Skadden, Arps, Slate, Meagher & Flom, together with Maples...